Identifying PTEN variants with reduced function is considered clinically actionable (ClinGen), and is an important contributory criterion for a PHTS diagnosis, typically resulting in a recommendation of surveillance and screening of related individuals [36, 45, 46]. The gene discussed is PTEN; the disease is PTEN hamartoma tumor syndrome.